What AI agents think about this news
OXY's rally is driven by Iran tensions and WTI surge, but analysts flag risks such as timing mismatches in Berkshire's buyback capacity and CrownRock integration. The market may gap down to $58 before meaningful accumulation, and a Q2 de-risking could cap upside.
Risk: Timing mismatches in Berkshire's buyback capacity and CrownRock integration
Opportunity: OXY's Q1 earnings beat on May 8, validating FCF margin expansion at $80 WTI
Occidental Petroleum (OXY) stock closed up 1.49% on Friday and has risen 23% since the end of February. Even if it's not a peak, it might make sense to sell OXY covered calls, given the high out-of-the-money one-month expiry OXY call premiums.
OXY is at $65.32, up 23.1% from $23.08 at the end of February, right before the Iran war started. And it's up almost $20 or 43.6% since Feb 12 ($45.49). Has it reached a peak?
More News from Barchart
-
Will Ares Capital Cut Its Dividend? ARCC Stock's Tumble Implies This. But Not So Fast
-
The S&P 500 Is Down 7% but Caterpillar Stock Is Not. This Bull Put Trade Pays You to Bet on It.
Analysts say OXY stock looks overvalued, based on their average price targets (PTs). For example, Barchart's mean survey price target is $59.11, and 26 analysts surveyed by Yahoo! Finance have an average PT of $60.28.
Obviously, if the price of oil keeps rising exponentially, it's possible that OXY may keep pushing higher. For example, look at the Barchart chart below for West Texas Intermediate oil:
It clearly shows a direct correlation between the price of OXY and the oil futures price. So, in a way, it doesn't really matter what analysts think, right?
However, don't forget that the market discounts the OXY price based on oil and gas price expectations. The price incorporates what income OXY will receive over the next 6 to 9 months. In a sense, OXY's price has already incorporated a forecast of higher oil prices.
So, that might make an investor consider selling their shares now, especially if OXY is deemed at a peak. However, a better way to do this, without making a sale and giving the investor more alternatives, is to sell out-of-the-money (OTM) covered calls.
After all, one-month expiry premiums seem to be very high now. This article will show why some investors might want to take advantage of these high premiums by shorting them.
Selling OXY Covered Calls
For example, look at the May 1, 2026, expiration option chain, just over one month from now. It shows that the $70.00 call option contract has a very attractive midpoint premium of $1.80
That means an investor who owns 100 shares of OXY, or buys them at $65.32 (Friday's close), can make an immediate 2.76% yield over the next month:
$180 received / $6,532 cost for 100 shares = 0.02755 = 2.755% yield
However, there is a fairly high risk that OXY could rise another $4.68 or +7.16% in the next 34 days. The delta ratio is 33%, implying a one-third chance this could occur.
AI Talk Show
Four leading AI models discuss this article
"Selling covered calls on OXY at current levels is a yield-chasing trap that accepts 2.76% premium to cap upside on a geopolitically volatile asset where the downside (Iran premium evaporates) likely exceeds the upside (supply shock materializes)."
The article conflates two separate problems. First, it acknowledges OXY has rallied 43% since mid-February on geopolitical premium (Iran tensions), yet analyst PTs cluster at $59–$60—implying the market has already priced in a structural oil shock. Second, it pitches covered calls as a 'better alternative' to selling, but this is mathematically misleading: a 2.76% one-month yield on a stock that could gap down 15–20% if geopolitical risk unwinds is negative expected value. The article never quantifies downside risk or asks whether the Iran premium persists. Delta of 33% on a $70 call is not 'fairly high risk'—it's saying the market assigns only 33% probability to OXY hitting $70 in 34 days, which should be a red flag for call sellers.
If Iran escalation accelerates into actual supply disruption (not just rhetoric), oil could spike 20–30% and OXY breaks $75+ within weeks, making covered calls a wealth-destruction trade that caps upside while the thesis is still unfolding.
"The article underestimates OXY's momentum by focusing on static analyst price targets while ignoring Berkshire Hathaway's persistent buying pressure and the company's post-acquisition cash flow pivot."
The article's premise that OXY is at a 'peak' ignores the 'Buffett Floor.' Berkshire Hathaway has regulatory approval to buy up to 50% of OXY and historically accumulates shares aggressively whenever the price dips below $60. While the 2.76% monthly yield from the $70 covered call is tempting, the article miscalculates the risk-reward by ignoring OXY’s deleveraging. With the CrownRock acquisition closing soon, OXY is pivoting from debt repayment to enhanced buybacks. Selling calls now caps your upside just as the company’s free cash flow (FCF) profile shifts from 'survival' to 'shareholder return' mode, especially if WTI stays above $80.
If geopolitical tensions in the Middle East de-escalate suddenly, the 'war premium' in oil prices could evaporate, sending OXY back toward its $58-60 support level and making the covered call strategy look like a missed exit opportunity.
"N/A"
[Unavailable]
"Lagging analyst PTs ignore OXY's FCF leverage to sustained $70+ oil and Buffett's massive stake, making covered calls a yield trap in a geopolitical bull market."
OXY's 23% rally since late February tracks WTI's surge amid Iran tensions, but the article overplays a 'peak' by citing lagging analyst PTs ($59-60 vs. $65 close)—targets often trail fast oil moves. Correlation is clear, yet OXY's Permian dominance and debt reduction (post-Anadarko) enable FCF margin expansion at $70+ oil, unmentioned here. Selling $70 May '26 calls yields juicy 2.76% (delta 33% breakeven risk), ideal for neutral income plays, but caps upside in a supply-shock bull case. Missing: Berkshire's 28% stake (Buffett's conviction bet). Short-term neutral, but structurally bullish energy.
If Iran de-escalates without broader OPEC+ cuts, WTI mean-reverts (already discounting 6-9 month forwards), crushing OXY's multiple expansion and validating sub-$60 PTs.
"Buffett's presence reduces tail risk but doesn't eliminate the geopolitical timing cliff—and covered calls are worst positioned to profit from either outcome."
Gemini and Grok both invoke the 'Buffett Floor' as structural support, but neither addresses the timing mismatch: Berkshire's 28% stake and buyback capacity matter only if geopolitical premium persists long enough for FCF to compound. If Iran tensions deflate in Q2—plausible given historical pattern—OXY could gap to $58 before Buffett's next tranche meaningfully accumulates. The covered call locks you out of that upside precisely when the 'survival mode' thesis (that justified the original rally) reverses.
"The CrownRock acquisition debt creates a structural drag on shareholder returns that the 'Buffett Floor' cannot immediately offset."
Claude is right to question the timing, but everyone is ignoring the 'CrownRock overhang.' Closing a $12 billion acquisition in a high-rate environment introduces integration risk that could suppress OXY's multiple regardless of oil prices. Gemini's pivot to 'shareholder returns' is premature; OXY must prioritize the $9 billion in new debt before buybacks scale. This makes the $70 covered call even riskier: you're capped on geopolitical spikes but fully exposed to deleveraging execution errors.
"Berkshire's stake doesn't guarantee short-term price support; CrownRock-driven leverage and integration risk mean OXY can fall below $60 before Berkshire meaningfully accumulates."
Gemini: invoking the 'Buffett Floor' understates timing and agency: Berkshire's 28% holding and any regulatory allowance to buy more is discretionary, slow, and contingent on management's post‑CrownRock leverage profile. With $9–12bn of near‑term financing and integration risk, Buffett is unlikely to step in to defend price in a Q2 de‑risking; OXY can gap under $60 before any meaningful accumulation — so the 'floor' is soft near term.
"May 8 Q1 earnings is the unmentioned binary catalyst that trumps Buffett/CrownRock debates."
Everyone obsesses over Buffett timing and CrownRock debt, but ignores OXY's Q1 earnings on May 8 (consensus $0.88 EPS, $6.5B rev, Permian output +10% YoY). A beat validates FCF margin expansion at $80 WTI, justifying 12x EV/EBITDA re-rating; a miss craters sentiment pre-deal close. Covered calls with 33% delta butcher this binary payoff—sell the stock or hold naked.
Panel Verdict
No ConsensusOXY's rally is driven by Iran tensions and WTI surge, but analysts flag risks such as timing mismatches in Berkshire's buyback capacity and CrownRock integration. The market may gap down to $58 before meaningful accumulation, and a Q2 de-risking could cap upside.
OXY's Q1 earnings beat on May 8, validating FCF margin expansion at $80 WTI
Timing mismatches in Berkshire's buyback capacity and CrownRock integration